U.S. markets closed

REGENXBIO Inc. (RGNX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
36.27+1.59 (+4.58%)
At close: 4:00PM EDT
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
No. of Analysts7787
Avg. Estimate-1.23-1.27-5.02-5.26
Low Estimate-1.68-1.73-6.79-7.26
High Estimate-0.93-0.95-3.93-3.49
Year Ago EPS-0.910.23-2.98-5.02
Revenue EstimateCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
No. of Analysts4476
Avg. Estimate29.02M34.5M111.15M135.37M
Low Estimate16.57M18.9M72.62M74.56M
High Estimate39.1M42.32M158.5M245.08M
Year Ago Sales22.07M21.37M154.57M111.15M
Sales Growth (year/est)31.50%61.40%-28.10%21.80%
Earnings History6/29/20209/29/202012/30/20203/30/2021
EPS Est.-0.89-1.01-0.43-1.28
EPS Actual-0.910.23-1.24-1.2
Difference-0.021.24-0.810.08
Surprise %-2.20%122.80%-188.40%6.30%
EPS TrendCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
Current Estimate-1.23-1.27-5.02-5.26
7 Days Ago-1.27-1.32-5.06-5.2
30 Days Ago-1.27-1.32-5.06-5.2
60 Days Ago-1.27-1.32-5.06-5.2
90 Days Ago-1.29-1.36-5.07-4.99
EPS RevisionsCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
Up Last 7 Days111N/A
Up Last 30 Days1111
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days1N/A11
Growth EstimatesRGNXIndustrySector(s)S&P 500
Current Qtr.-35.20%N/AN/AN/A
Next Qtr.-652.20%N/AN/AN/A
Current Year-68.50%N/AN/AN/A
Next Year-4.80%N/AN/AN/A
Next 5 Years (per annum)2.00%N/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A